Gland Pharma Ltd News
Gland Pharma jumps 5% after USFDA nod for Vitamin-K deficiency drug
Shares of Gland Pharma surged up to 4.76 per cent at Rs 1860 on the BSE in the early morning trade of Thursday
 "Gland Pharma jumps 5% after USFDA nod for Vitamin-K deficiency drug")
Here's why Gland Pharma share was up 3% on December 3; details here
The uptick in Gland Pharma share came after the company said that it has received approval from the United States Food and Drug Administration (US FDA) for Latanoprost Ophthalmic Solution
 "Here's why Gland Pharma share was up 3% on December 3; details here")
Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally
Individually, Cipla soared up to 3.68 per cent to hit an intraday high of Rs 1,547.70 per share, while Sun Pharma soared up to 3.30 per cent to hit an intraday high of Rs 1,791.60 per share
 "Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally")
Upper-teens EPS growth likely for Gland Pharma in next two financial years
Analysts are downgrading optimistic EPS estimates for FY25 and FY26, due to continuing slowdown in US sales and a temporary issue at Cenexi's site in Belgium
Gland Pharma soars 13% on better than expected Q2 performance
Despite increased EBITDA loss at Cenexi, the overall consolidated EBITDA margin was better-than-expected at 21.1%, led by better segmental mix and controlled operational cost for the quarter.
 "Gland Pharma soars 13% on better than expected Q2 performance")
Gland Pharma Q2FY25 results: Net profit falls 15.7% to Rs 164 crore
The company reported consolidated net profit of Rs 164 crore ($19.5 million) for the quarter ended Sept. 30, a 15.7 per cent decrease from the year-ago period
 "Gland Pharma Q2FY25 results: Net profit falls 15.7% to Rs 164 crore")
ACC, 2 pvt banks among 8 midcap stocks turn favourable on tech charts
The Nifty MidCap index has gained 3% from its recent low in the last three days. Amid this these 8 stocks have seen key momentum oscillators turn favourable on the daily chart.
 "ACC, 2 pvt banks among 8 midcap stocks turn favourable on tech charts")
Gland Pharma tanks 9% on weak June quarter show; Q1 profit drops 26%
The share price fell after the company reported a weak set of June quarter (Q1FY25) results.
 "Gland Pharma tanks 9% on weak June quarter show; Q1 profit drops 26%")
Gland Pharma Q1 FY25 results: Net profit falls 26%, revenue rises 16%
The decrease in the group's consolidated Ebitda margin is being attributed to the negative Ebitda reported by Cenexi, its recent acquisition
 "Gland Pharma Q1 FY25 results: Net profit falls 26%, revenue rises 16%")
USFDA issues 3 observations to Gland Pharma Hyderabad Unit, stock down 6%
The inspection at the Hyderabad facility took place between July 25, 2024 and August 02, 2024.
 "USFDA issues 3 observations to Gland Pharma Hyderabad Unit, stock down 6%")
